Zvonko Milicevic Selected Research

Insulin Lispro (Humalog)

10/2016	Continuous glucose monitoring in patients with type 2 diabetes treated with glucagon-like peptide-1 receptor agonist dulaglutide in combination with prandial insulin lispro: an AWARD-4 substudy.
5/2015	Once-weekly dulaglutide versus bedtime insulin glargine, both in combination with prandial insulin lispro, in patients with type 2 diabetes (AWARD-4): a randomised, open-label, phase 3, non-inferiority study.
9/2009	Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
9/2009	Efficacy and safety of AIR inhaled insulin compared to insulin lispro in patients with type 1 diabetes mellitus in a 6-month, randomized, noninferiority trial.
3/2009	Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
3/2005	Hyperglycemia and its effect after acute myocardial infarction on cardiovascular outcomes in patients with Type 2 diabetes mellitus (HEART2D) Study design.
12/2003	Therapy after single oral agent failure: adding a second oral agent or an insulin mixture?
3/2002	Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
1/2002	Comparative efficacy of preprandial or postprandial Humalog Mix75/25 versus glyburide in patients 60 to 80 years of age with type 2 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zvonko Milicevic Research Topics

Disease

26	Type 2 Diabetes Mellitus (MODY) 01/2022 - 01/2002
6	Hyperglycemia 03/2009 - 01/2002
5	Vomiting 01/2022 - 08/2014
5	Nausea 01/2022 - 08/2014
5	Body Weight (Weight, Body) 01/2021 - 01/2002
4	Weight Loss (Weight Reduction) 01/2021 - 11/2018
2	Insulin Resistance 01/2022 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018 - 09/2009
2	Latent Autoimmune Diabetes in Adults 01/2018 - 01/2018
2	Stroke (Strokes) 01/2016 - 07/2011
2	Myocardial Infarction 07/2011 - 03/2009
2	Cough 09/2009 - 09/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2005 - 02/2003
2	Hypoglycemia (Reactive Hypoglycemia) 12/2003 - 01/2002
1	Weight Gain 11/2017
1	Pancreatitis 01/2017
1	Abdominal Pain (Pain, Abdominal) 01/2017
1	Cardiogenic Shock 05/2015
1	Ventricular Fibrillation 05/2015
1	Pneumonia (Pneumonitis) 05/2015
1	Diarrhea 08/2014
1	Acute Coronary Syndrome 07/2011
1	Dyspnea (Shortness of Breath) 09/2009
1	Glucose Intolerance 02/2008
1	Diabetes Mellitus 11/2007
1	Infarction (Infarctions) 03/2005
1	Genetic Predisposition to Disease (Genetic Predisposition) 11/2003
1	Inflammation (Inflammations) 11/2003

Drug/Important Bio-Agent (IBA)

15	dulaglutideIBA 01/2021 - 08/2014
12	Insulin (Novolin)FDA Link 11/2017 - 03/2002
11	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2003
10	Glucagon-Like Peptide-1 ReceptorIBA 01/2022 - 08/2014
9	Insulin Lispro (Humalog)FDA Link 10/2016 - 01/2002
8	Blood Glucose (Blood Sugar)IBA 01/2022 - 02/2003
8	Insulin Glargine (Lantus)FDA Link 11/2019 - 03/2005
7	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2008
4	tirzepatideIBA 01/2022 - 11/2018
4	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021 - 10/2012
4	Hemoglobins (Hemoglobin)IBA 11/2017 - 12/2003
3	Peptides (Polypeptides)IBA 01/2022 - 11/2018
3	Sitagliptin Phosphate (Januvia)FDA Link 01/2017 - 08/2014
2	Exenatide (Byetta)FDA Link 01/2017 - 10/2012
2	Glyburide (Glibenclamide)FDA LinkGeneric 12/2003 - 01/2002
1	Glucagon (Glukagon)FDA Link 01/2022
1	semaglutideIBA 01/2022
1	AdiponectinIBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 1IBA 01/2021
1	Insulin-Like Growth Factor Binding Protein 2IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Gastric Inhibitory Polypeptide (Glucose Dependent Insulinotropic Peptide)IBA 01/2020
1	AntibodiesIBA 01/2018
1	SodiumIBA 01/2018
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2018
1	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2018
1	EnzymesIBA 01/2017
1	Liraglutide FDA Link 10/2012
1	Carbon MonoxideIBA 09/2009
1	InsulinsIBA 11/2007
1	isophane insulin lispro drug combination (25:75) insulin lisproIBA 12/2005
1	Isophane Insulin (NPH Insulin)FDA Link 03/2005
1	Fibrinogen (Factor I)FDA Link 11/2003
1	Plasminogen Activators (Plasminogen Activator)IBA 11/2003
1	Human Regular Insulin (Humulin)IBA 03/2002

Therapy/Procedure

5	Therapeutics 11/2018 - 01/2002
5	Glycemic Control 03/2009 - 01/2002
4	Injections 09/2009 - 12/2005
1	Subcutaneous Injections 01/2018